Search

everythinglearnresearchcommunity

for

Search:↓

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Isotretinoin effectively treats severe acne but can affect blood and inflammation markers, posing risks for some people.

Genetic differences affect COVID-19 severity and treatment effectiveness.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

Tannic acid helps wounds heal faster in rats by activating certain cell signals and reducing inflammation.

Two patients with psoriasis grew extra hair after using certain psoriasis medications.

A 589 nm laser increases IL-2 and IFN-y gene expression in human T-cells.

Bacteria can help skin regenerate through a process called IL-1β signaling.

Ajwain seed extract improved skin healing and hair growth in a mouse skin irritation model.

Minoxidil boosts hair growth by activating PGHS-1.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

The study found that two enzymes linked to hair loss are located in different parts of the scalp, supporting a common treatment's effectiveness.

Mice without the IL-6 gene had more hair growth after injury due to higher activity of a related protein, Stat3.

Higher interleukin-15 levels are linked to more severe alopecia areata, but not to age or gender.

A man's gray hair got darker and thicker after using a psoriasis drug.

A certain genetic variation in the IL1A gene may lower the risk of a hair loss condition in Chinese people.

Interleukin-6 may play a role in causing alopecia areata.

A man with hypoparathyroidism had other health issues that led to a diagnosis of a rare autoimmune disorder, APS-1.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

A 3-month treatment improved PCOS symptoms and reduced certain immune proteins.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Higher IL-17A levels indicate more severe alopecia areata.

H-1 antihistamines may help with various skin conditions, but more research is needed to confirm their effectiveness.

Targeting IL-17 could help treat pattern hair loss.

Cannabinoid receptor-1 signaling is essential for the survival and growth of human hair follicle stem cells.

Cepharanthine and berbamine may affect SK channels, influencing their therapeutic effects.

Certain gene variations may increase the risk and severity of alopecia areata.